Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11697832

Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2001 Sep
First author
Vansteenkiste JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2001 Sep;12(9):1191-3. doi: 10.1023/a:1012474308888.
    note
    Source null
    related pmid
    11697823
    relationship
    Comment in

Authors and identifiers

  1. name
    Vansteenkiste JF
    type
    Author
  2. name
    Vandebroek JE
    type
    Author
  3. name
    Nackaerts KL
    type
    Author
  4. name
    Weynants P
    type
    Author
  5. name
    Valcke YJ
    type
    Author
  6. name
    Verresen DA
    type
    Author
  7. name
    Devogelaere RC
    type
    Author
  8. name
    Marien SA
    type
    Author
  9. name
    Humblet YP
    type
    Author
  10. name
    Dams NL
    type
    Author
  11. name
    Leuven Lung Cancer Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Vansteenkiste JF
    type
    Author
  2. name
    Vandebroek JE
    type
    Author
  3. name
    Nackaerts KL
    type
    Author
  4. name
    Weynants P
    type
    Author
  5. name
    Valcke YJ
    type
    Author
  6. name
    Verresen DA
    type
    Author
  7. name
    Devogelaere RC
    type
    Author
  8. name
    Marien SA
    type
    Author
  9. name
    Humblet YP
    type
    Author
  10. name
    Dams NL
    type
    Author
  11. name
    Leuven Lung Cancer Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-51f7906f75caa9c7f331339d
book metadata
content sha256
a3d2c76228fa7caf8ab4010530877291553516a3681450c1d4ce529b90e4147b
document type
citation
dois
  1. 10.1023/a:1012208711013
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11697832
immutable id
pubmed:11697832@a3d2c76228fa7caf8ab4010530877291553516a3681450c1d4ce529b90e4147b
journal
abbreviation
Ann Oncol
issn electronic
Source null
issn print
0923-7534
issue
9
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
1221-30
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2001 Sep;12(9):1191-3. doi: 10.1023/a:1012474308888.
    note
    Source null
    related pmid
    11697823
    relationship
    Comment in
outcomes validated
false
pmid
11697832
provenance
batch id
bc1299bcdb6a81bdf655
provider
NCBI PubMed ESummary
record sha256
8828f7025b8780479193949d50c3ec947f7cf9473df3ecf163a7a982d51e3da1
response sha256
c4d63e9a162706394efcc7d20cd416503379c383137f167684654db2709afc4f
retrieved at
2026-09-09T23:45:42.126507+00:00
publication date
display
2001 Sep
precision
month
year
2001
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11697832/
title
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

Preserved source evidence · Not medical advice